Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Caveats in interpreting and applying pharmacoeconomic data

N E Cahill1

  • 1McDermott, Will & Emery, Chicago, IL 60606-5096, USA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Universal use of low-osmolality contrast media for the 1990s.

Radiology·1997
Same author

Influencing legislators on healthcare matters.

Radiology management·1996
Same author

Healthcare reform: what happened?

Radiology management·1996
Same author

The cost of complying with OSHA's bloodborne pathogens regulations.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1995
Same author

The impact of healthcare reform proposals on radiology practice.

Radiology management·1995
Same author

Reusable versus single-use laparoscopy instruments: who is responsible for patient safety?

Minimally invasive surgical nursing·1994

Pharmacoeconomic data requires careful interpretation, as cost containment can bias study methods and overlook patient costs. Honesty in reporting and informed consent are crucial to avoid legal issues and ensure patient well-being.

Area of Science:

  • Health Economics
  • Medical Ethics
  • Health Services Research

Background:

  • Cost containment pressures influence outcomes research, potentially leading to biased pharmacoeconomic study methods.
  • There's a tendency to adopt narrow perspectives, neglecting patient financial burdens and suffering.

Purpose of the Study:

  • To discuss cautions in interpreting and applying pharmacoeconomic data.
  • To highlight the ethical and legal implications of cost-driven research in healthcare.

Main Methods:

  • Critical analysis of pharmacoeconomic study methodologies.
  • Examination of the impact of cost containment on research perspectives.
  • Discussion of legal considerations, including tort liability and informed consent.

Related Experiment Videos

Main Results:

  • Pharmacoeconomic studies may prioritize short-term cost reduction over patient welfare.
  • Ignoring patient costs and suffering can lead to ethical and legal challenges.
  • Decisions in outcomes research must consider multiple stakeholder perspectives and institutional standards.

Conclusions:

  • Pharmacoeconomic research offers value in assessing cost-effectiveness but demands a comprehensive perspective.
  • Transparency, honesty in policymaking, and clear communication with patients are vital.
  • Adherence to ethical guidelines and legal standards is paramount in healthcare research and practice.